NV

Neemavat Vedantkumar Bharatbhai

Active Director Director DIN 11129657
DIN 11129657 First appointment May 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Neemavat Vedantkumar Bharatbhai

Data last updated:

Neemavat Vedantkumar Bharatbhai is a Director at Chemtix Pharmachem Private Limited (since 2025).

DIN 11129657
Primary Designation Director
First Appointment 29 May 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Chemtix Pharmachem Private Limited U46497GJ2025PTC163521
Director29 May 20252025Active

Board colleagues of Neemavat Vedantkumar Bharatbhai

NameDINCompanyDesignation
Hardikkumar Janakbhai Patel11129656Chemtix Pharmachem Private LimitedDirector

Directorship timeline

Open interactive timeline →
Chemtix Pharmachem Private Limited
Premium access

Shareholding and investment profile for Neemavat Vedantkumar Bharatbhai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neemavat Vedantkumar Bharatbhai

Neemavat Vedantkumar Bharatbhai currently holds 1 directorship: Chemtix Pharmachem Private Limited (Director, since 29 May 2025).

Neemavat Vedantkumar Bharatbhai was first appointed on 29 May 2025 as Director at Chemtix Pharmachem Private Limited.

The current boards of Neemavat Vedantkumar Bharatbhai's companies include Hardikkumar Janakbhai Patel (Chemtix Pharmachem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available